The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSchroder Income Growth Fund Regulatory News (SCF)

Share Price Information for Schroder Income Growth Fund (SCF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 289.00
Bid: 288.00
Ask: 290.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.694%)
Open: 290.00
High: 290.00
Low: 289.00
Prev. Close: 289.00
SCF Live PriceLast checked at -
Schroder Income Growth is an Investment Trust

To provide real growth of income, being growth of income in excess of the rate of inflation, and capital growth as a consequence of the rising income primarily in UK equities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Changes

18 Dec 2019 11:25

RNS Number : 3438X
Schroder Income Growth Fund PLC
18 December 2019
 

18 December 2019

Directorate Changes

Schroder Income Growth Fund plc (the "Company") is pleased to announce the appointment of Fraser McIntyre as an independent non-executive director of the Company, effective 17 December 2019. Mr McIntyre has also been appointed a member of the Audit and Risk, Nomination and Remuneration, and Management Engagement Committees.

Mr McIntyre has nearly 30 years of experience in financial services, including asset management, investment banking and audit. He started his career auditing financial services before working in the prime brokerage/equity divisions of two banks. He has been COO at several multi-billion dollar hedge funds where he was responsible for overseeing all operational areas of the business, including finance and accounting, operations, risk, legal and compliance. He has sat on a number of fund and management company boards whose investments covered a wide range of asset classes across traditional and alternative strategies.

Mr McIntyre is a Chartered Accountant. He has held a variety of executive positions within the financial services sector, most recently as Chief Operating Officer of Cantab Capital LLP which became part of GAM. It is confirmed that there are no other details to be disclosed concerning Mr McIntyre under Listing Rule 9.6.13 R.

At the date of this announcement, Mr McIntyre holds no interests in the shares of the Company.

The Company also announces that Ian Barby retired as a director of the Company at the annual general meeting held on 17 December 2019. The board would like to take this opportunity to thank Ian for his invaluable contribution to the Company over the last 14 years.

Enquiries:

Matthew Riley

Schroder Investment Management Limited

Tel: 020 7658 6596

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAGGGWPPUPBGGR
Date   Source Headline
8th Nov 20232:02 pmRNSDirector/PDMR Shareholding
8th Nov 202310:33 amRNSDirector/PDMR Shareholding
8th Nov 202310:23 amRNSNet Asset Value(s)
7th Nov 202310:52 amRNSNet Asset Value(s)
6th Nov 202311:57 amRNSNet Asset Value(s)
3rd Nov 202311:22 amRNSNet Asset Value(s)
2nd Nov 202310:56 amRNSNet Asset Value(s)
1st Nov 20235:11 pmRNSPortfolio Update
1st Nov 202310:24 amRNSNet Asset Value(s)
31st Oct 202310:20 amRNSNet Asset Value(s)
30th Oct 20234:02 pmRNSAnnual Financial Report on NSM
30th Oct 202310:32 amRNSNet Asset Value(s)
27th Oct 202310:55 amRNSResults analysis from Kepler Trust Intelligence
27th Oct 202310:34 amRNSNet Asset Value(s)
26th Oct 202310:43 amRNSNet Asset Value(s)
26th Oct 20237:00 amRNSFinal Results
25th Oct 202310:35 amRNSNet Asset Value(s)
24th Oct 202310:54 amRNSNet Asset Value(s)
23rd Oct 202311:25 amRNSNet Asset Value(s)
20th Oct 202310:34 amRNSNet Asset Value(s)
19th Oct 20235:23 pmRNSBlock listing Interim Review
19th Oct 202311:42 amRNSNet Asset Value(s)
18th Oct 202310:33 amRNSNet Asset Value(s)
17th Oct 202311:10 amRNSNet Asset Value(s)
16th Oct 202311:08 amRNSNet Asset Value(s)
13th Oct 202310:55 amRNSNet Asset Value(s)
12th Oct 202310:19 amRNSNet Asset Value(s)
11th Oct 202310:28 amRNSNet Asset Value(s)
10th Oct 202310:23 amRNSNet Asset Value(s)
9th Oct 202310:31 amRNSNet Asset Value(s)
6th Oct 202310:41 amRNSNet Asset Value(s)
5th Oct 202310:46 amRNSNet Asset Value(s)
4th Oct 202310:31 amRNSNet Asset Value(s)
3rd Oct 202311:42 amRNSNet Asset Value(s)
2nd Oct 20232:53 pmRNSPortfolio Update
2nd Oct 202311:42 amRNSInvestment in other listed closed-ended inv. fund
2nd Oct 202311:33 amRNSNet Asset Value(s)
29th Sep 202310:48 amRNSNet Asset Value(s)
28th Sep 202310:41 amRNSNet Asset Value(s)
27th Sep 202310:25 amRNSNet Asset Value(s)
26th Sep 20234:42 pmRNSDividend Declaration
26th Sep 202310:30 amRNSNet Asset Value(s)
25th Sep 202310:47 amRNSNet Asset Value(s)
22nd Sep 202310:25 amRNSNet Asset Value(s)
21st Sep 202311:01 amRNSNet Asset Value(s)
20th Sep 202310:33 amRNSNet Asset Value(s)
19th Sep 202310:56 amRNSNet Asset Value(s)
18th Sep 20234:40 pmRNSCompliance with Market Abuse Regulation
18th Sep 202310:40 amRNSNet Asset Value(s)
15th Sep 202311:31 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.